Journal Information
Most Often Read
37802
Hemoglobin value may be decreased in patients with severe coronavirus disease 2019Giuseppe Lippi, Camilla Mattiuzzi
Hematol Transfus Cell Ther. 2020;42:116-7
37802
Open access
Open Article
22670
COVID-19: RISCOS DA AUTO-HEMOTERAPIAD.S. Amorim, F.L.O. Lima, E.A.S. Costa
Hematol Transfus Cell Ther. 2020;42 Supl 2:528
22670
Open access
19068
CUIDADOS DE ENFERMAGEM NA TRANSFUSÃO SANGUÍNEAN.R.B. Gomes, N.T. Souza, S.R.S. Frantz, T.Q. Souza, E.G. Menezes, M.L.C. Oliveira, E.C. Cardoso
Hematol Transfus Cell Ther. 2020;42 Supl 2:507-8
19068
Open access
17288
D-DÍMERO ELEVADO EM PACIENTES COM COVID-19: RELATO DE UMA SEGUIMENTO CLÍNICO E LABORATORIAL EM 6 CASOS CONFIRMADOSM.E.G. Rocha, V.M. Chagas, L.G. Carvalho, V.R.S. Junior, A.Q.M.S. Aroucha, M.C.B. Correia, M.F.H. Costa
Hematol Transfus Cell Ther. 2020;42 Supl 2:528-9
17288
Open access
16038
Guidance on diagnosis, prevention and treatment of thromboembolic complications in COVID-19: a position paper of the Brazilian Society of Thrombosis and Hemostasis and the Thrombosis and Hemostasis Committee of the Brazilian Association of Hematology, Hemotherapy and Cellular TherapyFernanda Andrade Orsi, Erich V. De Paula, Fernanda de Oliveira Santos, Marcelo Melzer Teruchkin, Dirceu Hamilton Cordeiro Campêlo, Tayana Teixeira Mello, Maria Chiara Chindamo, Ariane Vieira Scarlatelli Macedo, Ana Thereza Rocha, Eduardo Ramacciotti, Ana Clara Kneese Nascimento, Joyce Annichino-Bizzacchi, Dayse Maria Lourenco, João Carlos de Campos Guerra, Suely Meireles Rezende, Cyrillo Cavalheiro Filho
Hematol Transfus Cell Ther. 2020;42:300-8
16038
Open access
Open Article
9914
INFECÇÃO POR COVID-19 E ANEMIA FALCIFORME: UMA REVISÃO DE LITERATURAF.G.F. Rocha, A.L.J.F. Campos, M.R.F. Teixeira, M.G. Vanderlei, L.F.B. Botelho
Hematol Transfus Cell Ther. 2020;42 Supl 2:540
9914
Open access
9221
DEFICIÊNCIA DE VITAMINA B12 E SINTOMAS PSIQUIÁTRICOS: RELATO DE CASOB.Y.F. Toi, J.M. Sasseron, V.F. Alves, M.S.E.S. Arcadipane, J.C.G.C. Sarinho
Hematol Transfus Cell Ther. 2020;42 Supl 2:21-2
9221
Open access
7128
USO DA AUTO-HEMOTERAPIA EM PACIENTES COM COVID-19: REVISÃO SISTEMÁTICAB.C.R. Silva, M.O. Andrade, G.P. Bertholucci, J.F. Carneiro, J.F. Fernandes, B.M.S. Gomes, T.C.A. Gomes, P.P. Katopodis, L.F.M. Moraes, A.M.T.C. Silva
Hematol Transfus Cell Ther. 2020;42 Supl 2:565
7128
Open access
7123
INFECÇÃO POR HIV E TIPO SANGUÍNEO EM DOADORES DE SANGUE DE UM HEMOCENTRO BRASILEIROG.T. Nunes, M.E. Lopes, S.O.G. Mateos
Hematol Transfus Cell Ther. 2020;42 Supl 2:366-7
7123
Open access
6574
DESCRIÇÃO DAS ALTERAÇÕES DO HEMOGRAMA CORRELACIONADOS À PROTEÍNA C REATIVA (PCR) E FERRITINA EM 7942 PACIENTES COM COVID-19D.M. Jacinto, T.Z. Ferreira, I.Y. Takihi, A. Firmiano, J. Sá, A.D.S.B. Perazzio, M.C.A. Silva, M.V. Gonçalves, A.F. Sandes, M.L.L.F. Chauffaille
Hematol Transfus Cell Ther. 2020;42 Supl 2:529-30
6574
Open access
Special content about COVID-19
- Effect of ABO blood groups on length of hospital stay according to age in Covid-19 patients
- Response to queries about “COVID-19 and adult acute lymphoblastic leukemia: Presentation and management”
- Antibody response against SARS-CoV-2 in convalescent plasma donors: Can we predict subjects’ eligibility?
- Regarding management of COVID-19 in acute lymphoblastic leukemia
Publish in
Hematology, Transfusion and Cell Therapy
Hematology, Transfusion and Cell Therapy is a member and subscribes the principles of, the Committee on Publication Ethics (COPE)
www.publicationethics.org.
www.publicationethics.org.